Clinical Trial Update: MET-PET for Newly Diagnosed Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

A MET-PET imaging study for newly diagnosed Glioblastoma has completed its EARLY Phase 1 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma | EARLY_Phase 1 | Status: COMPLETED